RESUMO
BACKGROUND: The etiology of myxomatous mitral valve degeneration (MVD) is not fully understood and may depend on time or environmental factors for which the interaction of infectious agents has not been documented. The purpose of the study is to analyze the effect of Mycoplasma pneumoniae (Mp), Chlamydophila pneumoniae (Cp) and Borrelia burgdorferi (Bb) on myxomatous mitral valve degeneration pathogenesis and establish whether increased in inflammation and collagen degradation in myxomatous mitral valve degeneration etiopathogenesis. METHODS: An immunohistochemical test was performed to detect the inflammatory cells (CD20, CD45, CD68) and Mp, Bb and MMP9 antigens in two groups. The in situ hybridization was performed to detect Chlamydophila pneumoniae and the bacteria study was performed using transmission electron microscopy. Group 1 (n = 20), surgical specimen composed by myxomatous mitral valve degeneration, and group 2 (n = 20), autopsy specimen composed by normal mitral valve. The data were analyzed using SigmaStat version 20 (SPSS Inc., Chicago, IL, USA). The groups were compared using Student's t test, Mann-Whitney test. A correlation analysis was performed using Spearman's correlation test. P values lower than 0.05 were considered statistically significant. RESULTS: By immunohistochemistry, there was a higher inflammatory cells/mm2 for CD20 and CD45 in group 1, and CD68 in group 2. Higher number of Mp and Cp antigens was observed in group 1 and more Bb antigens was detected in group 2. The group 1 exhibited a positive correlation between the Bb and MVD percentage, between CD45 and Mp, and between MMP9 with Mp. These correlations were not observed in the group 2. Electron microscopy revealed the presence of structures compatible with microorganisms that feature Borrelia and Mycoplasma characteristics. CONCLUSIONS: The presence of infectious agents, inflammatory cells and collagenases in mitral valves appear to contribute to the pathogenesis of MVD. Mycoplasma pneumoniae was strongly related with myxomatous mitral valve degeneration. Despite of low percentage of Borrelia burgdorferi in MD group, this agent was correlated with myxomatous degeneration and this may occour due synergistic actions between these infectious agents likely contribute to collagen degradation.
Assuntos
Borrelia burgdorferi/patogenicidade , Chlamydophila pneumoniae/patogenicidade , Valva Mitral/microbiologia , Valva Mitral/patologia , Mycoplasma pneumoniae/patogenicidade , Idoso , Estudos de Casos e Controles , Chicago , Chlamydophila pneumoniae/genética , Colágeno/metabolismo , Feminino , Humanos , Imuno-Histoquímica , Masculino , Metaloproteinase 9 da Matriz/metabolismo , Microscopia Eletrônica de Transmissão , Pessoa de Meia-Idade , Insuficiência da Valva Mitral/patologia , Miocardite/microbiologia , Miocardite/patologia , Fatores de RiscoRESUMO
Background: Idiopathic dilated cardiomyopathy (IDCM) myocardial inflammation may be associated with external triggering factors such as infectious agents. Here, we searched if moderate/severe heart transplantation rejection is related to the presence of myocardial inflammation in IDCM explanted hearts, associated with microbial communities. Method: Receptor myocardial samples from 18 explanted hearts were separated into groups according to post-transplant outcome: persistent moderate rejection (PMR; n = 6), moderate rejection (MR; n = 7) that regressed after pulse therapy, and no rejection (NR; n = 5)/light intensity rejection. Inflammation was quantified through immunohistochemistry (IHC), and infectious agents were evaluated by IHC, molecular biology, in situ hybridization technique, and transmission electron microscopy (TEM). Results: NR presented lower numbers of macrophages, as well as B cells (p = 0.0001), and higher HLA class II expression (p ≤ 0.0001). PMR and MR showed higher levels of Mycoplasma pneumoniae (p = 0.003) and hepatitis B core (p = 0.0009) antigens. NR presented higher levels of parvovirus B19 (PVB19) and human herpes virus 6 (HHV6) and a positive correlation between Borrelia burgdorferi (Bb) and enterovirus genes. Molecular biology demonstrated the presence of M. pneumoniae, Bb, HHV6, and PVB19 genes in all studied groups. TEMâ¯revealed structures compatible with the cited microorganisms. Conclusions: This initial study investigating on infectious agents and inflammation in the IDCM explanted hearts showed that the association between M. pneumoniae and hepatitis B core was associated with a worse outcome after HT, represented by MR and PMR, suggesting that different IDCM microbial communities may be contributing to post-transplant myocardial rejection.
Assuntos
Cardiomiopatia Dilatada , Microbiota , Parvovirus B19 Humano , Coração , Humanos , MiocárdioRESUMO
Microbial communities are considered decisive for maintaining a healthy situation or for determining diseases. Acute myocardial infarction (AMI) is an important complication of atherosclerosis caused by the rupture of atheroma plaques containing proinflammatory cytokines, reactive oxygen species, oxidized low-density lipoproteins (oxLDL), damaged proteins, lipids, and DNA, a microenvironment compatible with a pathogenic microbial community. Previously, we found that archaeal DNA-positive infectious microvesicles (iMVs) were detected in vulnerable plaques and in the sera of Chagas disease patients with heart failure. Now, we characterize and quantify the levels of serum microbiome extracellular vesicles through their size and content using morphomolecular techniques to differentiate clinical outcomes in coronary artery disease (CAD). We detected increased numbers of large iMVs (0.8-1.34 nm) with highly negative surface charge that were positive for archaeal DNA, Mycoplasma pneumoniae antigens and MMP9 in the sera of severe AMI patients, strongly favoring our hypothesis that pathogenic archaea may play a role in the worst outcomes of atherosclerosis. The highest numbers of EVs <100 nm (exosomes) and MVs from 100 to 200 nm in the stable atherosclerotic and control healthy groups compared with the AMI groups were indicative that these EVs are protective, entrapping and degrading infectious antigens and active MMP9 and protect against the development of plaque rupture. Conclusion: A microbiome with pathogenic archaea is associated with high numbers of serum iMVs in AMI with the worst prognosis. This pioneering work demonstrates that the morphomolecular characterization and quantification of iEVs in serum may constitute a promising serum prognostic biomarker in CAD.
RESUMO
BACKGROUND: Clinical and experimental conflicting data have questioned the relationship between infectious agents, inflammation and dilated cardiomyopathy (DCM). OBJECTIVES: The aim of this study was to determine the frequency of infectious agents and inflammation in endomyocardial biopsy (EMB) specimens from patients with idiopathic DCM, explanted hearts from different etiologies, including Chagas' disease, compared to donated hearts. METHODS: From 2008 to 2011, myocardial samples from 29 heart donors and 55 patients with DCMs from different etiologies were studied (32 idiopathic, 9 chagasic, 6 ischemic and 8 other specific etiologies). Inflammation was investigated by immunohistochemistry and infectious agents by immunohistochemistry, molecular biology, in situ hybridization and electron microscopy. RESULTS: There were no differences regarding the presence of macrophages, expression of HLA class II and ICAM-I in donors and DCM. Inflammation in Chagas' disease was predominant. By immunohistochemistry, in donors, there was a higher expression of antigens of enterovirus and Borrelia, hepatitis B and C in DCMs. By molecular biology, in all groups, the positivity was elevated to microorganisms, including co-infections, with a higher positivity to adenovirus and HHV6 in donors towards DCMs. This study was the first to demonstrate the presence of virus in the heart tissue of chagasic DCM. CONCLUSIONS: The presence of inflammation and infectious agents is frequent in donated hearts, in the myocardium of patients with idiopathic DCM, myocardial dysfunction related to cardiovascular diseases, and primary and secondary cardiomyopathies, including Chagas' disease. The role of co-infection in Chagas' heart disease physiopathology deserves to be investigated in future studies.
Assuntos
Cardiomiopatia Dilatada/diagnóstico , Cardiomiopatia Dilatada/microbiologia , Doença de Chagas/diagnóstico , Doença de Chagas/microbiologia , Coração/microbiologia , Doadores de Tecidos , Adulto , Cardiomiopatias/diagnóstico , Cardiomiopatias/microbiologia , Feminino , Transplante de Coração/normas , Humanos , Inflamação/diagnóstico , Inflamação/microbiologia , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Adulto JovemRESUMO
OBJECTIVE: To study atheromas, Mycoplasma pneumoniae (M. pneumoniae), and Chlamydia pneumoniae (C. pneumoniae). METHODS: C. pneumoniae was studied with immunohistochemistry and M. pneumoniae with in situ hybridization (ISH), in segments of coronary arteries (SCA) as follows: group A - thrombosed ruptured plaques (TRP) of 23 patients who died due to acute myocardial infarction (AMI); group B - 23 nonruptured plaques (NRP) of group A patients; group C - NRP of 11 coronary patients who did not die due to AMI; and group D - 11 SCA from patients with dilated cardiomyopathy or Chagas' disease without atherosclerosis. RESULTS: The mean number of C. pneumoniae+ cells/400x in groups A, B, C, and D was, respectively, 3.3 +/- 3.6; 1.0 +/- 1.3; 1.2 +/- 2.4; and 0.4 +/- 0.3; and the percentage of M. pneumoniae area was, respectively, 3.9 +/- 3.5; 1.5 +/- 1.6; 0.9 +/- 0.9; and 0.4 +/- 0.2. More M. pneumoniae and C. pneumoniae were found in of group A than in group B (P<0.01). Good correlation was seen between the area of the vessel and the M. pneumoniae area in the plaque (r = 0.46; P=0.001) and between C. pneumoniae+ cells and CD4+ T lymphocytes (r = 0.42; P<0.01). The number of C. pneumoniae+ cells correlated with CD20+ B cells (r=0.48; P<0.01). CONCLUSION: M. pneumoniae and C. pneumoniae are more frequently found in TRP correlate with the intensity of the inflammation and diameter of the vessel (positive remodeling).
Assuntos
Infecções por Chlamydia/complicações , Doença da Artéria Coronariana/microbiologia , Infarto do Miocárdio/microbiologia , Pneumonia por Mycoplasma/complicações , Idoso , Cardiomiopatia Dilatada/microbiologia , Doença de Chagas/microbiologia , Chlamydophila pneumoniae/isolamento & purificação , Chlamydophila pneumoniae/ultraestrutura , Doença da Artéria Coronariana/patologia , Feminino , Humanos , Masculino , Mycoplasma pneumoniae/isolamento & purificação , Mycoplasma pneumoniae/ultraestrutura , Infarto do Miocárdio/patologia , Ruptura EspontâneaRESUMO
A presente revisão descreve os principais achados anatomopatológicos que caracterizam a cardiopatia chagásica crônica, discute a teoria autoimune e parassimpaticopriva que dominaram a explicação patogenética nas ultimas décadas e propõe novos caminhos a partir de achados mais recentes. Esses achados se relacionam com a presença de outros microrganismos que talvez tenham sejam levados até o miocárdio por estarem em simbiose com o T. cruzi, como micoplasmas, clamídias e arqueias. As arqueias têm como característica aumentar a inflamação por apresentarem antígenos aos linfócitos T CD8+. A inflamação exacerbada pode levar à vasodilatação da microcirculação e à falha na distribuição de sangue no miocárdio, ocasionando áreas de isquemia em regiões distais de dupla irrigação. Isto explicaria as regiões de afilamento e dilatação aneurismática ventricular, bem como a fibrose e infiltração gordurosa do sistema de condução (feixe de His, nó sinoatrial e atrioventricular). Esses microrganismos no interior da fibra cardíaca podem induzir uma resposta imunológica com fibrose ao redor dos cardiomiócitos, os quais se tornam extremamente hipertróficos por não entrarem em apoptose. A simbiose entre esses microrganismos pode levar à produção de micropartículas infecciosas que circulam e fazem parte da patogenia da descompensação cardíaca. Assim, a ação terapêutica na doença de Chagas deveria incluir a eliminação simultânea desses diferentes microrganismos e não somente do T. cruzi
This review describes the main anatomopathological findings that characterize chronic Chagasic cardiomyopathy, discusses the autoimmune and parasympathetic dysautonomia theories that have dominated the pathogenic explanation in recent decades, and proposes new routes based on the most recent findings. These findings relate to the presence of other microorganisms, such as micoplasmas, chlamydias and archaea, that are perhaps carried to the myocardium as they are in symbiosis with T. cruzi. A characteristic of archaea is that they increase inflammation by presenting T CD8+ lymphocyte antigens. Exacerbated inflammation may lead to vasodilation of the microcirculation and failure of blood distribution in the myocardium, leading to areas of ischemia in distal regions of double irrigation. This would explain the regions of thinning and dilation of the ventricular aneurysm, as well as the fibrosis and fatty infiltration of the conduction system (His bundle, sinoatrial node and atrioventricular node). These microorganisms in the interior of the heart fiber may lead to an immunological response with fibrosis around the cardiomyocytes, which become extremely hypertrophic, as they do not enter apoptosis. The symbiosis between these microorganisms can lead to the production of infectious microparticles that circulate and form part of the pathogenesis of decompensated heart failure. The therapeutic conduct in Chagas disease should therefore include the simultaneous elimination of these different microorganisms, and not only of T. cruzi
Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Adulto , Arritmias Cardíacas/complicações , Doença de Chagas/patologia , Insuficiência Cardíaca/etiologia , Trypanosoma cruzi/parasitologia , Infecções/diagnóstico , Inflamação/diagnósticoRESUMO
The membrane attack complex (MAC) of complement participates in several inflammatory and proliferative processes by releasing pro-inflammatory cytokines and growth factors from target cells. Chronic Chagasic cardiomyopathy (CCH) is a parasitic dilated cardiopathy, characterized by severe fibrosis and inflammation, which differs from idiopathic dilated cardiomyopathy (DCM). Trypanosoma cruzi, the pathogenic organism of CCH, is a strong complement activator and can also induce alternative pathway activation by mammalian cells. This study explored whether the myocardium in CCH patients has increased MAC deposition, an expression of complement activation, compared to DCM patients. MAC was semi-quantified in endomyocardial human samples (29 CCH subjects, 18 DCM subjects, and four controls) by immunohistochemistry. MAC was present in the sarcolemma of 38% of CCH, 5.5% of DCM (p<0.02), and 0% of controls, and in interstitial inflammatory cells of CCH. No difference was observed in the expression of the complement regulatory protein CD59, indicating that increased MAC deposition is likely to be the result of complement activation rather than decreased protection. It is proposed that the increased MAC deposition found in CCH, but not in DCM or controls, may help to explain the diffuse myocardial fibrosis and inflammation characteristic of the disease.
Assuntos
Cardiomiopatia Chagásica/imunologia , Complexo de Ataque à Membrana do Sistema Complemento/análise , Miocárdio/imunologia , Adulto , Antígenos CD59/análise , Cardiomiopatia Dilatada/imunologia , Doença Crônica , Ativação do Complemento , Vasos Coronários/imunologia , Humanos , Pessoa de Meia-Idade , Estudos Retrospectivos , Sarcolema/imunologiaRESUMO
Neste trabalho, quantificamos fatores de crescimento em fragmentos de miocárdio de 19 cardiopatas chagásicos crônicos com insuficiência cardíaca congestiva, através da técnica da imunoperoxidase. Pesquisamos: antígenos de T. cruzi, fatores de crescimento...
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Fatores de Crescimento de Fibroblastos , Fibrose Endomiocárdica/patologia , Cardiomiopatia Chagásica , Receptor alfa de Fator de Crescimento Derivado de Plaquetas , Fator de Crescimento Transformador beta , Antígenos de Protozoários , Cardiomiopatias , Doença Crônica , Imuno-Histoquímica , Insuficiência Cardíaca , Miocárdio , Estudos de Avaliação como AssuntoRESUMO
Os autores descrevem os aspectos anátomo-patológicos de 16 coraçöes obtidos de necrópsia de paciente falecidos devido à leishmaniose visceral (LV). As alteraç öes histológicas foram mais proeminentes, porém nunca em grau intenso, no miocárdio e consistiram de edema, infiltraçäo linfocitária, necrose focal e proliferaçäo dos miócitos de Anitschkow. Estas alteraçöes, quando tomadas em conjunto estabeleceram o diagnóstico de miocardite focal em somente um dos casos. Os demais exibiram alteraçöes que parecem representar o que se pode denominar de "miocárdio reacional". A pesquisa de Leishmania donovani tanto nas coloraçöes de rotina quanto através de métodos de imunoperoxidase resultou negativa. Doze (75%) dos pacientes tinham broncopneumonia bacteriana (BCP) e/ou sepse associada; por isto foi questionado se o dano cardíaco foi realmente secundário a estas infecçöes ou à LV. Para rersolver esta questäo foi idealizado um grupo controle composto por pacientes que faleceram devido a doenças bacterianas agudas e sem LV. Verificou-se que elas näo diferiram das alteraçöes vistas no grupo LV. Entretanto estas mesmas alteraçöes estiveram também presentes em quatro caso com LV que näo apresentavam infecçöes bacterianas associadas, incluindo o caso com miocardite. Estes resultados levaram-nos a concluir que há comprometimento cardíaco no curso da LV; no entanto ele é pouco intenso e consiste no que se pode denominar "miocárdio reacional". As infecçöes bacterianas associadas podem contribuir para as alteraçöes histológicas encontradas
Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lactente , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Leishmaniose Visceral/patologia , Miocárdio/patologia , Broncopneumonia/patologia , Sepse/patologia , Miocardite/patologiaRESUMO
OBJECTIVE: To study atheromas, Mycoplasma pneumoniae (M. pneumoniae), and Chlamydia pneumoniae (C. pneumoniae). METHODS: C. pneumoniae was studied with immunohistochemistry and M. pneumoniae with in situ hybridization (ISH), in segments of coronary arteries (SCA) as follows: group A - thrombosed ruptured plaques (TRP) of 23 patients who died due to acute myocardial infarction (AMI); group B - 23 nonruptured plaques (NRP) of group A patients; group C - NRP of 11 coronary patients who did not die due to AMI; and group D - 11 SCA from patients with dilated cardiomyopathy or Chagas' disease without atherosclerosis. RESULTS: The mean number of C. pneumoniae+ cells/400x in groups A, B, C, and D was, respectively, 3.3±3.6; 1.0±1.3; 1.2±2.4; and 0.4±0.3; and the percentage of M. pneumoniae area was, respectively, 3.9±3.5; 1.5± 1.6; 0.9±0.9; and 0.4±0.2. More M. pneumoniae and C. pneumoniae were found in of group A than in group B (P<0.01). Good correlation was seen between the area of the vessel and the M. pneumoniae area in the plaque (r = 0.46; P=0.001) and between C. pneumoniae+ cells and CD4+ T lymphocytes (r = 0.42; P<0.01). The number of C. pneumoniae+ cells correlated with CD20+ B cells (r=0.48; P<0.01). CONCLUSION: M. pneumoniae and C. pneumoniae are more frequently found in TRP correlate with the intensity of the inflammation and diameter of the vessel (positive remodeling)